eligibility for clinicaltrials:NCT01838174 [clinicaltrials_resource:6a9c2f313487a7b08a30c72372ec2fea]
eligibility [clinicaltrials_vocabulary:eligibility]
eligibility for clinicaltrials:NCT01838174 [clinicaltrials_resource:6a9c2f313487a7b08a30c72372ec2fea]
Bio2RDF identifier
6a9c2f313487a7b08a30c72372ec2fea
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:6a9c2f313487a7b08a30c72372ec2fea
gender [clinicaltrials_vocabulary:gender]
healthy volunteers [clinicaltrials_vocabulary:healthy-volunteers]
maximum age [clinicaltrials_vocabulary:maximum-age]
minimum age [clinicaltrials_vocabulary:minimum-age]
text [clinicaltrials_vocabulary:text]
Inclusion Criteria:
...... urrent use of 4-aminopyridine.
identifier
clinicaltrials_resource:6a9c2f313487a7b08a30c72372ec2fea
title
eligibility for clinicaltrials:NCT01838174
@en
type
label
eligibility for clinicaltrials ...... c2f313487a7b08a30c72372ec2fea]
@en